Cyclin-dependent kinase 10 and tumorigenesis

Abstract

YOU Yan-Jie, LI Wen-Mei, LIU Jia-Jia, YUAN Yi. Cyclin-dependent kinase 10 and tumorigenesis[J]. Journal of International Oncology, 2014, 41(11): 811-812.

［1］ Yasutis KM, Kozminski KG. Cell cycle checkpoint regulators reach a zillion［J］. Cell Cycle, 2013, 12(10):15011509. ［2］ Yeh CW, Kao SH, Cheng YC. Knockdown of cyclindependent kinase 10 (cdk10) impairs neural progenitor survival via modulation of raf1a expression［J］. J Biol Chem, 2013, 288(39):2792727939. ［3］ Marquardt JU, Seo D, GómezQuiroz LE, et al. Loss of cMet accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways［J］. Biochim Biophys Acta, 2012, 1822(6):942951. ［4］ Yu JH, Zhong XY, Zhang WG, et al. CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells［J］. Oncol Rep， 2012， 27(4):12661276. ［5］ Zhong XY, Xu XX, Yu JH, et al. Clinical and biological significance of Cdk10 in hepatocellular carcinoma［J］. Gene, 2012, 498(1):6874. ［6］ You Y, Yang W, Wang Z, et al. Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas［J］. Cell Oncol (Dordr), 2013, 36(4):323331. ［7］ Leman ES, Magheli A, Yong KM, et al. Identification of nuclear structural protein alterations associated with seminomas［J］. J Cell Biochem， 2009， 108(6):12741279. ［8］ You Y, Chen Y, Zheng X, et al. Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients［J］. Cancer Lett, 2012, 315(2):138144. ［9］ Toyota M, Suzuki H, Yamashita T, et al. Cancer epigenomics: implications of DNA methylation in personalized cancer therapy［J］. Cancer Sci, 2009, 100(5):787791. ［10］ Ran Y, Wu S, You Y. Demethylation of Ecadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy［J］. J Biochem, 2011, 149(1):4954. ［11］ Heller G, Ziegler B, Brandstetter A, et al. CDK10 is not a target for aberrant DNA methylation in breast cancer［J］. Anticancer Res, 2009, 29(10):39393944. ［12］ Guen VJ, Gamble C, Flajolet M, et al. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome［J］. Proc Natl Acad Sci USA, 2013, 110(48):1952519530. ［13］ Liu Y, Xiao Z, Yang D, et al. Effects of the cyclindependent kinase 10 (CDK10) on the tamoxifen sensitivity of keloid samples［J］. Molecules, 2012, 17(2):13071318. ［14］ Zheng T, Nibau C, Phillips DW, et al. CDKG1 protein kinase is essential for synapsis and male meiosis at high ambient temperature in Arabidopsis thaliana［J］. Proc Natl Acad Sci USA, 2014,111(6):21822187. ［15］ Khanal P, Yun HJ, Lim SC, et al. Proyl isomerase Pin1 facilitates ubiquitinmediated degradation of cyclindependent kinase 10 to induce tamoxifen resistance in breast cancer cells［J］. Oncogene, 2012, 31(34):38453856. ［16］ Liu W， Cai MJ， Wang JX， et al. In a nongenomic action, steroid hormone 20hydroxyecdysone induces phosphorylation of cyclindependent kinase 10 to promote gene transcription［J］. Endocrinology, 2014, 155(5):17385170.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Cyclin-dependent kinase 10 and tumorigenesis

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments